| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |